Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APC resistance as an additional thrombotic risk factor in a patient suffering from polycythemia vera and recurrent thrombosis.

Annals of hematology - 1 Jan 1997

Lamparter S, Schuermann M, Heidtmann H H

Abstract excerpt

Patients with polycythemia vera (PV) have a high risk of thrombosis. However, thrombosis is not sufficiently predictable with standard diagnostic procedures. We report on a patient with PV and recurrent thrombosis who nevertheless had a low platelet count while under therapy with hydroxyurea. As a result of duodenal ulcer and gastrointestinal bleeding, treatment with phenprocoumon was stopped years ago. Recently,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance
Share to Enzyme Activation
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to APC gene

Share to Heterozygote

Share to Mutation

Share to Protein C

Share to Risk Factors

Source

Identifiers

PMID: 9031617
DOI: 10.1007/s002770050256

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APC resistance as an additional thrombotic risk factor in a patient suffering from polycythemia vera and recurrent thrombosis.PMID 9031617Read ↗

Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.Semantic proximity Read ↗

Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.Semantic proximity Read ↗

Diagnosis and clinical characteristics of inherited activated protein C resistance.Semantic proximity Read ↗

Heparin-induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistance.Semantic proximity Read ↗

Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.Semantic proximity Read ↗

Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.Semantic proximity Read ↗

Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.Semantic proximity Read ↗

[Activated protein C resistance and factor V Leiden: clinical interest].Semantic proximity Read ↗

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Semantic proximity Read ↗

Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.Semantic proximity Read ↗

Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.Semantic proximity Read ↗

Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.